Two Types of Liposomal Formulations Improve the Therapeutic Ratio of Prednisolone Phosphate in a Zebrafish Model for Inflammation
Open Access
Abstract
Glucocorticoids (GCs) are effective anti-inflammatory drugs, but their clinical use is limited by their side effects. Using liposomes to target GCs to inflammatory sites is a promising approach to improve their therapeutic ratio. We used zebrafish embryos to visualize the biodistribution of liposomes and to determine the anti-inflammatory and adverse effects of the GC prednisolone phosphate (PLP) encapsulated in these liposomes. Our results showed that PEGylated liposomes remained in circulation for long periods of time, whereas a novel type of liposomes (which we named AmbiMACs) selectively targeted macrophages. Upon laser wounding of the tail, both types of liposomes were shown to accumulate near the wounding site. Encapsulation of PLP in the PEGylated liposomes and AmbiMACs increased its potency to inhibit the inflammatory response. However, encapsulation of PLP in either type of liposome reduced its inhibitory effect on tissue regeneration, and encapsulation in PEGylated liposomes attenuated the activation of glucocorticoid-responsive gene expression throughout the body. Thus, by exploiting the unique possibilities of the zebrafish animal model to study the biodistribution as well as the anti-inflammatory and adverse effects of liposomal formulations of PLP, we showed that PEGylated liposomes and AmbiMACs increase the therapeutic ratio of this GC drug.Keywords
Funding Information
- China Scholarship Council (201606040176)
- Leiden/Huygens Scholarship grant (/)
This publication has 68 references indexed in Scilit:
- Liposomal Targeting of Prednisolone Phosphate to Synovial Lining Macrophages during Experimental Arthritis Inhibits M1 Activation but Does Not Favor M2 DifferentiationPLOS ONE, 2013
- Drug delivery systems: An updated reviewInternational Journal of Pharmaceutical Investigation, 2012
- Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: Comparison of prednisolone with budesonideInternational Journal of Pharmaceutics, 2011
- Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritisInternational Journal of Pharmaceutics, 2011
- Targeted drug delivery to tumors: Myths, reality and possibilityJournal of Controlled Release, 2011
- mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafishBlood, 2011
- Glucocorticosteroids: current and future directionsBritish Journal of Pharmacology, 2010
- Multimodal Clinical Imaging To Longitudinally Assess a Nanomedical Anti-Inflammatory Treatment in Experimental AtherosclerosisMolecular Pharmaceutics, 2010
- Prevention and treatment of systemic glucocorticoid side effectsInternational Journal of Dermatology, 2010
- Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseasesJournal of The Royal Society Interface, 2009